# Viatris Inc. - Inspection Records

Source: https://www.keypedia.com/companies/viatris-inc/e65d242e-4279-4e07-992f-5f241792c2cf

> Inspection records and compliance data for Viatris Inc. in Morgantown, West Virginia. Access full analysis and detailed observations.

---

## Details

- Name: Viatris Inc.
- FEI Number: 1110315
- City: Morgantown
- State: West Virginia
- Country Name: United States
- Address Line 1: 3711 Collins Ferry Rd
- Zip Code: 26505
- Facility Type: Finished Drug Product Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK

## Related Documents

- [FDA Inspection 1311680 - Viatris Inc. - 2026-04-28](https://www.keypedia.com/records/fda_inspections/viatris-inc/f51818fb-20e4-4712-84fe-90bae363c52d) — classification: No Action Indicated (NAI), source: FDA, date: April 28, 2026
- [WARNING_LETTER - Viatris Inc. - 2024-06-26](https://www.keypedia.com/records/warning_letter/viatris-inc/486d0c63-dd02-4bd9-a54c-75405be98540) — source: FDA, date: June 26, 2024
- [FDA Inspection 1219018 - Viatris Inc. - 2023-08-18](https://www.keypedia.com/records/fda_inspections/viatris-inc/f27e7a90-3421-42b9-a6ea-e1d6f4ec77ae) — classification: No Action Indicated (NAI), source: FDA, date: August 18, 2023
- [483 - Viatris Inc. - 2022-05-26](https://www.keypedia.com/records/483/viatris-inc/8ba662c8-1553-4929-bc10-4fe7831bbf9c) — source: FDA, date: May 26, 2022
- [FDA Inspection 1170444 - Viatris Inc. - 2022-05-26](https://www.keypedia.com/records/fda_inspections/viatris-inc/1e12ba24-b71a-4a92-a8d1-421fe3edfa03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2022
- [483 - Viatris Inc. - 2019-08-15](https://www.keypedia.com/records/483/viatris-inc/9e200adb-c8fe-45a3-bf9b-b1fdcc0a6b7d) — source: FDA, date: August 15, 2019
- [FDA Inspection 1099590 - Viatris Inc. - 2019-08-15](https://www.keypedia.com/records/fda_inspections/viatris-inc/ce0dbe8c-6a9e-4ed3-ac81-5c9508c700af) — classification: No Action Indicated (NAI), source: FDA, date: August 15, 2019
- [FDA Inspection 1099590 - Viatris Inc. - 2019-08-15](https://www.keypedia.com/records/fda_inspections/viatris-inc/c3d3e8fd-9d6c-4f73-a069-fd791615bece) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 15, 2019
- [483 - Viatris Inc. - 2019-07-25](https://www.keypedia.com/records/483/viatris-inc/5ad9b2c3-4f0d-434b-9011-3fcc0d10111e) — source: FDA, date: July 25, 2019
- [FDA Inspection 1076082 - Viatris Inc. - 2018-11-09](https://www.keypedia.com/records/fda_inspections/viatris-inc/357e5935-b403-4e92-b2e0-38bee760b6b8) — classification: No Action Indicated (NAI), source: FDA, date: November 9, 2018
- [FDA Inspection 1072148 - Viatris Inc. - 2018-11-07](https://www.keypedia.com/records/fda_inspections/viatris-inc/6b08dccf-aabd-41bd-b7bb-9f7cdea62a57) — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2018
- [483 - Viatris Inc. - 2018-04-12](https://www.keypedia.com/records/483/viatris-inc/24a2a7cc-647e-427c-9f53-a9a19e40ec12) — source: FDA, date: April 12, 2018
- [FDA Inspection 1044577 - Viatris Inc. - 2018-03-01](https://www.keypedia.com/records/fda_inspections/viatris-inc/1274a8dc-1371-4841-9859-f19a121db987) — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2018
- [483 - Viatris Inc. - 2016-11-18](https://www.keypedia.com/records/483/viatris-inc/afa3589b-bae0-4641-aa0e-5f252d238128) — source: FDA, date: November 18, 2016
- [FDA Inspection 994523 - Viatris Inc. - 2016-11-18](https://www.keypedia.com/records/fda_inspections/viatris-inc/2b758c3a-d5cd-4006-840a-fcddec0b8089) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 18, 2016
- [FDA Inspection 933105 - Viatris Inc. - 2015-04-24](https://www.keypedia.com/records/fda_inspections/viatris-inc/7af5bcab-fca3-4fa9-a8c8-b9cf844f2062) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 24, 2015

## Related Companies

- [Eurofins Lancaster Laboratories, Inc](https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890)
- [Kobo Products, Inc](https://www.keypedia.com/companies/kobo-products-inc/998595c1-1a50-4600-8360-16c81c7e6d7b)
- [Pacific BioLabs](https://www.keypedia.com/companies/pacific-biolabs/3b9d5ef3-bc95-4934-9be0-40c8534a1bde)
- [Astellas Pharma US Inc.](https://www.keypedia.com/companies/astellas-pharma-us-inc/3bb1b330-7226-4071-b93b-2854ea7577cb)
- [SEAGEN INC.](https://www.keypedia.com/companies/seagen-inc/07c5dcb3-661e-4212-adfc-a00316850e38)
- [Meridian Medical Technologies, LLC a Subsidiary of Kindeva Drug Delivery, L.P.](https://www.keypedia.com/companies/meridian-medical-technologies-llc-a-subsidiary-of-kindeva-drug-delivery-lp/00b844de-fb09-432d-96ab-31b8f7192a5d)
- [Lloyd Inc. of Iowa](https://www.keypedia.com/companies/lloyd-inc-of-iowa/b4573054-1b28-4619-88ea-c42615aede75)
- [WuXi AppTec Inc.](https://www.keypedia.com/companies/wuxi-apptec-inc/9d289339-3edc-4d2e-aacb-4d849335e75d)
- [New Jersey Laboratories](https://www.keypedia.com/companies/new-jersey-laboratories/d310e635-49c8-4881-97d4-757fe831e691)
- [Curia New Jersey, LLC](https://www.keypedia.com/companies/curia-new-jersey-llc/3487be34-bea7-4920-8489-0c360d8868f0)

## Related Officers

- [Regulatory Affairs](https://www.keypedia.com/people/atul-j-agrawal/7c9fab5d-a13f-4217-a6fc-9dfc0bbbd555)
- [Senior Program Coordinator](https://www.keypedia.com/people/chaltu-nwakijra/fb7fd592-2118-4547-af1e-92f61dc5ad94)
- [Supervisory Consumer Safety Officer, China Office](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)
- [Regulatory Counsel at FDA with a PharmD and JD](https://www.keypedia.com/people/melissa-t-roy/4aa8cad9-af71-45fd-a2c9-326a06f754c9)
- [Investigator](https://www.keypedia.com/people/guerlain-ulysse/aeef6f71-43b1-4116-b563-8bb3f2966d6a)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)
